Cefadroxil is a first-generation oral cephalosporin effective against Gram-positive skin pathogens and susceptible urinary tract organisms, valued for its long half-life permitting convenient twice-daily dosing. Simson Pharma's Cefadroxil reference standard and impurities support IP/BP/USP/EP compendial testing.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cefadroxil Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.